ULBP6 engages the NKG2D-based costimulatory module to enhance T-cell activation, but killing is triggered by CAR recognition of CLDN18.2; cytotoxicity occurs via T-cell degranulation (perforin/granzymes) against CLDN18.2-positive cells, not by ULBP6 alone.